The representative organizations for European community, hospital and industrial pharmacists have issued a joint call for action by governments, regulators and the European Commission to tackle the growing problem of medicines shortages.
Presenting evidence at the European Parliament on the scale of the difficulties being experienced across sectors, spokespeople from the Pharmaceutical Group of the European Union (PGEU), the European Association of Hospital Pharmacists (EAHP) and the European Industrial Pharmacists Group (EIPG) called for:
• heightened awareness by governments and national regulators of the critical impacts medicines shortages have in relation to patient welfare and safety, and the accompanying need for urgent action;
• greater investigation of the impact that national strategies on medicines pricing and reimbursement are having on the operation of the supply chain; and
• better sharing and implementation of best practices between countries in responding to medicines shortage, including the operation of information portals and early warning systems.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze